China approves scientific trials of 16 Covid vaccines

Image Source : AP China approves scientific trials of 16 Covid vaccines
China has authorized 16 domestically made Covid-19 vaccines for scientific trials, six of which have entered section 3, in accordance with the most recent information from the National Medical Products Administration.
Two inactivated Covid-19 vaccines from China have hit the market on a conditional foundation: a vaccine from China National Biotec Group affiliated with Sinopharm, and the CoronaVac vaccine developed by Sinovac Biotech. They acquired their respective approvals from the administration on December 30, 2020, and February 5 this 12 months, Xinhua information company reported.

In addition to inactivated vaccines, China has adopted 4 technological approaches to Covid-19 vaccines: recombinant protein vaccines, adenovirus vector vaccines, nucleic acid vaccines, and vaccines utilizing attenuated influenza viruses as vectors.
As of February 9, China has administered 40.52 million Covid-19 vaccine doses to key teams, mentioned National Health Commission spokesperson Mi Feng at a press convention.
ALSO READ | China’s crackdown in opposition to pretend covid vaccines, smuggling; over 80 arrested, 3,000 jabs seized
Latest World News